Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

62.11 -1.63 (-2.56%)
Official Closing Price Updated: 4:10 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
56 57 Next >
3 Overlooked Stocks With Strong Value and Dividend Potential
Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term. 
Via MarketBeat
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution. 
Via Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
CVS Shares Are Trading Lower Wednesday: What You Need To Know
CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which has created a wave of uncertainty in the healthcare sector. Here's what... 
Via Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
What 9 Analyst Ratings Have To Say About CVS Health
Via Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
Via Benzinga
Interest Rates, Private Equity, Stocks, Football...We've Got It All
Including an interview with former NFL linebacker Brandon Copeland. 
Via The Motley Fool
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives. 
Via Benzinga
CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit With the Schall Law Firm
From The Schall Law Firm
Via Business Wire
What the Options Market Tells Us About CVS Health
Via Benzinga
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
From The Law Offices of Frank R. Cruz
Via Business Wire
CVS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Rosen Law Firm Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action with an Expanded Class Period– CVS
From The Rosen Law Firm, P.A.
Via Business Wire
Peering Into CVS Health's Recent Short Interest
Via Benzinga
This Is What Whales Are Betting On CVS Health
Via Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
These stocks offer above-average yields ranging between 2.8% and 5.1%. 
Via The Motley Fool
CVS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip?
Shares of the dividend-paying pharmacy chain have been offering a double-digit yield percentage. 
Via The Motley Fool
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
These stocks have been dealing with some ire from investors. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Patchy But Still Bullish
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations. 
Via Talk Markets
CVS Stock: Low Multiple, High Dividend. What Could Possibly Go Wrong?
Chasing yield without conducting proper due diligence could be bad for your financial health. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback